Scarica l'app Stockscreener
15.52
2.04%
0.31
Dopo l'orario di chiusura:
15.52
Precedente Chiudi:
$15.21
Aprire:
$15.27
Volume 24 ore:
176.98K
Relative Volume:
0.54
Capitalizzazione di mercato:
$560.94M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-1.34%
1M Prestazione:
-13.34%
6M Prestazione:
-33.22%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$15.15
$15.89
Intervallo di 1 settimana:
$15.15
$16.04
Portata 52W:
$10.01
$32.75
Ceribell Inc Stock (CBLL) Company Profile
Nome
Ceribell Inc
Settore
Industria
Telefono
(800) 436-0826
Indirizzo
360 N. PASTORIA AVENUE, SUNNYVALE
Confronta CBLL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CBLL
Ceribell Inc
|
15.52 | 568.53M | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
125.73 | 228.77B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
103.16 | 153.09B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
395.15 | 149.27B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
91.65 | 114.31B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.30 | 45.06B | 5.54B | 4.18B | 623.10M | 7.00 |
Ceribell Inc Stock (CBLL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-24 | Iniziato | BTIG Research | Buy |
| 2025-04-04 | Iniziato | Ladenburg Thalmann | Buy |
| 2024-11-05 | Iniziato | BofA Securities | Buy |
| 2024-11-05 | Iniziato | Canaccord Genuity | Buy |
| 2024-11-05 | Iniziato | JP Morgan | Overweight |
| 2024-11-05 | Iniziato | TD Cowen | Buy |
| 2024-11-05 | Iniziato | William Blair | Outperform |
Mostra tutto
Ceribell Inc Borsa (CBLL) Ultime notizie
Is CeriBell Inc. a good long term investmentSuperior stock selection - jammulinksnews.com
CeriBell Inc. Stock Analysis and ForecastSuperior stock growth - jammulinksnews.com
Ceribell to Report Second Quarter 2025 Financial Results on August 5, 2025 - The Manila Times
What drives CeriBell Inc. stock priceOver 200% growth - Autocar Professional
What analysts say about CeriBell Inc. stockExceptional gains - printweek.in
How CeriBell Inc. stock performs during market volatilityReturn Optimized Trade Insights - Newser
Brokerages Set CeriBell, Inc. (NASDAQ:CBLL) Price Target at $32.14 - Defense World
What makes CeriBell Inc. stock price move sharplyFast Gains With Reduced Risk - Newser
Why CeriBell Inc. stock attracts strong analyst attentionWeekly Double Return List - Newser
CeriBell shares drop 38% following InvestingPro’s overvaluation warning By Investing.com - Investing.com South Africa
Ceribell sues Natus Medical for patent infringement - MSN
Ceribell, Inc.’s Strategic Positioning and Patent Strength Justify Buy Rating - TipRanks
Ceribell (CBLL) CEO Chao sells $442,500 in stock By Investing.com - Investing.com South Africa
Ceribell (CBLL) CEO Chao sells $442,500 in stock - Investing.com
Ceribell files patent infringement complaints against Natus Medical By Investing.com - Investing.com South Africa
Ceribell's IP Offense: How Legal Aggression Could Spark a Neurotech Breakout - AInvest
Ceribell files patent infringement complaints against Natus Medical - Investing.com Australia
Ceribell's Legal Offense and Pediatric Breakthrough: A Strategic Double Play for Market Dominance - AInvest
Ceribell Files Patent Infringement Complaints Against Natus - TipRanks
CeriBell Files Patent Infringement Complaints Against Natus Medical - MarketScreener
Ceribell sues Natus Medical for patent infringement (CBLL) - Seeking Alpha
Ceribell files complaints against Natus Medical, alleges patent infringement - TipRanks
CeriBell, Inc. Files Patent Infringement Complaints Against Natus Medical Incorporated - Nasdaq
Ceribell Files Complaints Against Natus Medical Incorporated with the U.S. International Trade Commission and Federal Court in Delaware - GlobeNewswire
Ceribell Hits Competitor With Patent Lawsuit Over Wearable EEG - Bloomberg Law News
Rhumbline Advisers Buys 3,276 Shares of CeriBell, Inc. (NASDAQ:CBLL) - Defense World
Ceribell Inc Azioni (CBLL) Dati Finanziari
Non sono disponibili dati finanziari per Ceribell Inc (CBLL). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
1.64%
0.34%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):